
According to the South Korean team, doctors in China are interested in a partnership and learning more about an experimental drug that it has developed to combat the disease.
The team’s study, titled “Oxidative stress-induced astrocytic collagen biosynthesis drives glial barrier formation and neuronal death in ischemic stroke,” was published online last week in the journal Cell Metabolism.
Advertisement
Ischemic stroke occurs when a blood clot or other blockage obstructs a cerebral blood vessel, cutting off oxygen and nutrients and causing brain cells to die.
Advertisement
Survivors often suffer severe aftereffects, including motor disabilities and cognitive decline. Treatment is further complicated by a narrow three-hour “golden time” window after symptom onset, during which patients must receive emergency care.

Don't Miss:
-
Singapore, New Zealand sign world’s first bilateral treaty to protect essential trade
-
Hong Kong extends tax waiver for residents displaced by deadly Tai Po fire
-
Paralysed dancer Mo Li testifies in court for first time over Mirror concert accident
-
Why African leaders value seamless transcontinental links over US-China rivalry
-
China son calls mum to say he ‘might not return’ while saving driver from burning truck

Australia and Indonesia: Differing Regional Visions
Vietnam at 51
Arizona gun shop owner faces terrorism-related charges for allegedly selling high-caliber weapons bound for Mexican cartels